Cargando…

In silico Method in CRISPR/Cas System: An Expedite and Powerful Booster

The CRISPR/Cas system has stood in the center of attention in the last few years as a revolutionary gene editing tool with a wide application to investigate gene functions. However, the labor-intensive workflow requires a sophisticated pre-experimental and post-experimental analysis, thus becoming o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yuwei, Zhao, Guofang, Ahmed, Fatma Yislam Hadi, Yi, Tianfei, Hu, Shiyun, Cai, Ting, Liao, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567020/ https://www.ncbi.nlm.nih.gov/pubmed/33123486 http://dx.doi.org/10.3389/fonc.2020.584404

Ejemplares similares

Function and regulation annotation of up‐regulated long non‐coding RNA LINC01234 in gastric cancer
por: Zhu, Yinyin, et al.
Publicado: (2020)

Regulatory Network Analysis of Mutated Genes Based on Multi-Omics Data Reveals the Exclusive Features in Tumor Immune Microenvironment Between Left-Sided and Right-Sided Colon Cancer
por: Yi, Tianfei, et al.
Publicado: (2021)

CaSilico: A versatile CRISPR package for in silico CRISPR RNA designing for Cas12, Cas13, and Cas14
por: Asadbeigi, Adnan, et al.
Publicado: (2022)

Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUAD
por: Zhang, Yuwei, et al.
Publicado: (2020)

Network analysis of KLF5 targets showing the potential oncogenic role of SNHG12 in colorectal cancer
por: Liao, Qi, et al.
Publicado: (2020)

Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer
por: Zhu, Wenhui, et al.
Publicado: (2020)

Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance
por: Wang, Kun, et al.
Publicado: (2019)

The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
por: Wang, Luyao, et al.
Publicado: (2022)

Structural insights into the inactivation of CRISPR-Cas systems by diverse anti-CRISPR proteins
por: Zhu, Yuwei, et al.
Publicado: (2018)

The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening
por: Chen, Jun-Zhu, et al.
Publicado: (2023)

The Power of Iodide of Potassium in Expediting Mercurial Salivation
por: Kelly, Bernard
Publicado: (1860)

CRISPR/Cas9: a powerful tool in colorectal cancer research
por: Hu, Yang, et al.
Publicado: (2023)

CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
por: Lu, Tongyi, et al.
Publicado: (2020)

Derivation and Validation of a Prognostic Model for Cancer Dependency Genes Based on CRISPR-Cas9 in Gastric Adenocarcinoma
por: Zhou, Wenjie, et al.
Publicado: (2021)

Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
Publicado: (2021)

Development of a Novel Reference Material for Tumor Mutational Burden Measurement Based on CRISPR/Cas9 Technology
por: Peng, Rongxue, et al.
Publicado: (2022)

In silico optimization of RNA–protein interactions for CRISPR-Cas13-based antimicrobials
por: Park, Ho-min, et al.
Publicado: (2022)

From bench to bedside, 2-in-1 design expedites phase 2/3 oncology drug development
por: Chen, Cong, et al.
Publicado: (2023)

CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model
por: Felce, Suet Ling, et al.
Publicado: (2020)

Evolution of Molecular Targeted Cancer Therapy: Mechanisms of Drug Resistance and Novel Opportunities Identified by CRISPR-Cas9 Screening
por: Hou, Jue, et al.
Publicado: (2022)

CRISPR/Cas9(-3NLS)/sgHMGA2@PDA nanosystem is the potential efficient gene editing therapy for gastric cancer with HMGA2 high expression
por: Wu, Zhouying, et al.
Publicado: (2022)

Nanotechnology Powered CRISPR-Cas Systems for Point of Care Diagnosis and Therapeutic
por: Li, Chen-zhong, et al.
Publicado: (2022)

CRISPR-Cas-Docker: web-based in silico docking and machine learning-based classification of crRNAs with Cas proteins
por: Park, Ho-min, et al.
Publicado: (2023)

The Impact of CRISPR-Cas System on Antiviral Therapy
por: Bayat, Hadi, et al.
Publicado: (2018)

CRISPR-dCas9-Based Artificial Transcription Factors to Improve Efficacy of Cancer Treatment With Drug Repurposing: Proposal for Future Research
por: Martinez-Escobar, Alejandro, et al.
Publicado: (2021)

Expedition
Publicado: (1959)

Recent advances in structural studies of the CRISPR-Cas-mediated genome editing tools
por: Zhu, Yuwei, et al.
Publicado: (2019)

CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses
por: Yuan, Ming, et al.
Publicado: (2016)

CRISPR-Cas9: A Powerful Tool to Efficiently Engineer Saccharomyces cerevisiae
por: Rainha, João, et al.
Publicado: (2020)

CRISPR/Cas: A powerful tool for gene function study and crop improvement
por: Zhang, Dangquan, et al.
Publicado: (2020)

CRISPR/Cas9: A Powerful Strategy to Improve CAR-T Cell Persistence
por: Wei, Wei, et al.
Publicado: (2023)

CRISPR/Cas13a Powered Portable Electrochemiluminescence Chip for Ultrasensitive and Specific MiRNA Detection
por: Zhou, Ting, et al.
Publicado: (2020)

The Positive Lymph Node Ratio Predicts Survival in T(1−4)N(1−3)M(0) Non-Small Cell Lung Cancer: A Nomogram Using the SEER Database
por: Liao, Yi, et al.
Publicado: (2020)

Bioethical issues in genome editing by CRISPR-Cas9 technology
por: AYANOĞLU, Fatma Betül, et al.
Publicado: (2020)

Reversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System
por: Wan, Peng, et al.
Publicado: (2020)

An expedition to geometry
por: Kumaresan, S, et al.
Publicado: (2005)

The expedition of Cyrus
por: Xenophon
Publicado: (1828)

The tigris expedition
por: Heyerdahl, Thor
Publicado: (1980)

The RA expeditions
por: Heyerdahl, Thor
Publicado: (1970)

The Looshai Expedition
por: Smith, W. C.
Publicado: (1872)

Cannot write session to /tmp/vufind_sessions/sess_gvfg0i2sbtqb08du2of16cr2kf